Patents by Inventor Tobias Ölschläger

Tobias Ölschläger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant Escherichia Coli Strains
    Publication number: 20160015781
    Abstract: The present invention is directed to a recombinant E. coli Nissle 1917 (EcN) cell transformed with a nucleic acid coding for a defensin protein or a derivative thereof. The invention is further directed to a pharmaceutical composition comprising this cell and a pharmaceutically acceptable carrier as well as a method of producing a recombinant E. coli Nissle 1917 cell and its use in the treatment of Crohn's disease.
    Type: Application
    Filed: February 14, 2013
    Publication date: January 21, 2016
    Inventors: Tobias Ölschläger, Ean Jeong Seo, Jan Wehkamp, Eduard F. Stange, Ulrich Sonnenborn, Jürgen Malinka, Hans Proppert
  • Plasmid-free clone of strain DSM 6601
    Patent number: 7993902
    Abstract: The invention relates to a plasmid-free clone of Escherichia coli strain DSM 6601, to a method for preparing the same and to the use thereof as a cloning vehicle.
    Type: Grant
    Filed: June 25, 2004
    Date of Patent: August 9, 2011
    Assignee: Pharma-Zentrale GmbH
    Inventors: Jorg Hacker, Tobias Oelschlaeger, Sibylle Oswald, Ulrich Sonnenborn, Hans Proppert
  • Plasmid-free clone of e. coli strain dsm 6601
    Publication number: 20060094117
    Abstract: The invention relates to a plasmid-free clone of Escherichia coli strain DSM 6601, to a method for preparing the same and to the use thereof as a cloning vehicle.
    Type: Application
    Filed: June 25, 2004
    Publication date: May 4, 2006
    Applicant: Pharma-Zentrale GmbH
    Inventors: Jorg Hacker, Tobias Oelschlaeger, Sibylle Oswald, Ulrich Sonnenborn, Hans Proppert